Treuer Harald, Hoevels Moritz, Luyken Klaus, Visser-Vandewalle Veerle, Wirths Jochen, Kocher Martin, Ruge Maximilian
Department of Stereotaxy and Functional Neurosurgery, University Hospital Cologne, Cologne, Germany,
Strahlenther Onkol. 2015 Jun;191(6):470-6. doi: 10.1007/s00066-014-0786-y. Epub 2014 Nov 22.
Stereotactic radiosurgery with an adapted linear accelerator (linac-SRS) is an established therapy option for brain metastases, benign brain tumors, and arteriovenous malformations. We intended to investigate whether the dosimetric quality of treatment plans achieved with a CyberKnife (CK) is at least equivalent to that for linac-SRS with circular or micromultileaf collimators (microMLC).
A random sample of 16 patients with 23 target volumes, previously treated with linac-SRS, was replanned with CK. Planning constraints were identical dose prescription and clinical applicability. In all cases uniform optimization scripts and inverse planning objectives were used. Plans were compared with respect to coverage, minimal dose within target volume, conformity index, and volume of brain tissue irradiated with ≥ 10 Gy.
Generating the CK plan was unproblematic with simple optimization scripts in all cases. With the CK plans, coverage, minimal target volume dosage, and conformity index were significantly better, while no significant improvement could be shown regarding the 10 Gy volume. Multiobjective comparison for the irradiated target volumes was superior in the CK plan in 20 out of 23 cases and equivalent in 3 out of 23 cases. Multiobjective comparison for the treated patients was superior in the CK plan in all 16 cases.
The results clearly demonstrate the superiority of the irradiation plan for CK compared to classical linac-SRS with circular collimators and microMLC. In particular, the average minimal target volume dose per patient, increased by 1.9 Gy, and at the same time a 14% better conformation index seems to be an improvement with clinical relevance.
采用适配直线加速器的立体定向放射外科治疗(直线加速器立体定向放射外科治疗,linac-SRS)是脑转移瘤、良性脑肿瘤和动静脉畸形的既定治疗选择。我们旨在研究射波刀(CK)治疗计划的剂量学质量是否至少等同于采用圆形或微型多叶准直器(微型MLC)的直线加速器立体定向放射外科治疗。
随机抽取16例曾接受直线加速器立体定向放射外科治疗的患者,其有23个靶区体积,用射波刀重新制定治疗计划。计划约束条件为相同的剂量处方和临床适用性。所有病例均使用统一的优化脚本和逆向计划目标。对计划在覆盖范围、靶区内最小剂量、适形指数以及接受≥10 Gy照射的脑组织体积方面进行比较。
在所有病例中,使用简单的优化脚本生成射波刀计划都没有问题。采用射波刀计划时,覆盖范围、最小靶区体积剂量和适形指数明显更好,而在10 Gy体积方面未显示出显著改善。23例中的20例,射波刀计划中照射靶区体积的多目标比较更优,23例中的3例相当。16例患者中,射波刀计划在所有病例的多目标比较中更优。
结果清楚地表明,与采用圆形准直器和微型MLC的传统直线加速器立体定向放射外科治疗相比,射波刀的照射计划具有优越性。特别是,每位患者的平均最小靶区体积剂量增加了1.9 Gy,同时适形指数提高了14%,这似乎是具有临床意义的改善。